TD Cowen Analyst Raises Merck Target Price to $155
TD Cowen analyst Steve Scala has maintained his hold rating for Merck & Co (MRK.US) and increased the target price from $137 to $155. This decision is based on the analyst's track record, with a success rate of 62.5% and an average return of 10.0% over the past year.
According to TipRanks data, Scala's virtual portfolio has earned a positive return from Merck & Co shares. The analyst's performance is evaluated based on his total success rate and average return, which have led to him receiving a 5-star ranking from TipRanks.